Curriculum Registration

The Emerging Role of Biologics in COPD Management

Credits Available: 3.50 AMA PRA Category 1 Credit™

Description: Chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, is a heterogeneous lung condition characterized by chronic respiratory symptoms caused by persistent airflow limitation due to airway and alveolar abnormalities. Initial COPD management relies on bronchodilators with the addition of inhaled corticosteroids for those at high risk for exacerbations. However, up to half of patients on triple therapy still experience exacerbations, highlighting a need for new therapies. Biologic therapy targeting type 2 inflammation, which is common in COPD and associated with exacerbation risk, has recently been approved for clinical use as add-on maintenance treatment of adult patients with inadequately controlled COPD and an eosinophilic phenotype. This educational program is designed to get pulmonology experts up to date on these rapid treatment advances for COPD as well as to bolster standard-of-care fundamentals.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:
Forgot Password

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Pulmonary/Respiratory Physician

Azeem Elahi

CaroMont Health

Dr. Azeem Elahi is an established and highly skilled physician with specialty training in Pulmonary, Critical Care and Sleep Medicine. He is well regarded in the region by colleagues as an exceptional clinician and by patients as someone who establishes a deep connection to foster open dialogue and shared decision making. Dr. Elahi strives to collaborate with other health care team members to encourage a team-based approach to the care of patients and is continually seeking to broaden his knowledge and procedural competency.